Daiichi Sankyo Co Ltd (4568) – Company Profile and SWOT Analysis

Daiichi Sankyo Co Ltd (4568) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Daiichi Sankyo Co Ltd (Daiichi Sankyo) is a global healthcare company that focuses on the discovery, development, and delivery of innovative medical solutions. The company offers a wide range of prescription drugs, over the counter (OTC) drugs, vaccines, and others. Its portfolio encompasses medicines for cardiovascular, neurological, nephrological, diabetic, metabolic, and infectious diseases, and various types of cancers. Besides cancer, the company’s other research areas include rare diseases and immune disorders. Daiichi Sankyo sells its products through its group companies and an extensive network of medical representatives. It has operations in North America, South and Central America, Europe, and Asia. Daiichi Sankyo is headquartered in Tokyo, Japan.

Scope

• Detailed information on Daiichi Sankyo Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Daiichi Sankyo Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Daiichi Sankyo Co Ltd including a breakdown and examination of key business segments

• News about Daiichi Sankyo Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Daiichi Sankyo Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Daiichi Sankyo Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Daiichi Sankyo Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Takeda Pharmaceutical Co Ltd

Mitsubishi Tanabe Pharma Corp

Sumitomo Pharma Co Ltd

Kaken Pharmaceutical Co Ltd

Chugai Pharmaceutical Co Ltd

Shionogi & Co Ltd

Astellas Pharma Inc

Taisho Pharmaceutical Holdings Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Daiichi Sankyo Co Ltd - Key Facts

Daiichi Sankyo Co Ltd - Key Employees

Daiichi Sankyo Co Ltd - Key Employee Biographies

Daiichi Sankyo Co Ltd - Major Products and Services

Daiichi Sankyo Co Ltd - History

Daiichi Sankyo Co Ltd - Company Statement

Daiichi Sankyo Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Daiichi Sankyo Co Ltd - Business Description

Product Category: Healthcare (OTC) Products

Overview

Performance

Product Category: Others

Performance

Product Category: Prescription Drugs

Overview

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

Geographical Segment: North America

Performance

Geographical Segment: Other Regions

Performance

R&D Overview

Daiichi Sankyo Co Ltd - Corporate Strategy

Daiichi Sankyo Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Daiichi Sankyo Co Ltd - Strengths

Daiichi Sankyo Co Ltd - Weaknesses

Daiichi Sankyo Co Ltd - Opportunities

Daiichi Sankyo Co Ltd - Threats

Daiichi Sankyo Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Daiichi Sankyo Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 21, 2024: Daiichi Sankyo Establishes New Subsidiaries In Mexico And Colombia

Aug 07, 2024: Daiichi Sankyo and MSD expand collaboration on ADC development

Jul 10, 2024: Daiichi Sankyo Launches New Affiliate for Oncology in Greece

Jun 28, 2024: Arbitration Dispute between Daiichi Sankyo and Seagen Ends

May 29, 2024: New Subgroup Analyses of CLEAR Outcomes Data Showed Bempedoic Acid Reduced the Risk of Major Adverse Cardiovascular Events Across Various Patient Groups

May 22, 2024: Daiichi Sankyo Establishes Two Research Institutes In The U.S. And EU

May 21, 2024: Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

May 14, 2024: Daiichi Sankyo Announces Appointments Of Directors

Mar 12, 2024: Lung Cancer Research Foundation Announces Research Grant Awards

Mar 12, 2024: Daiichi Sankyo Adopts Genedata Biologics to Automate the Discovery of Novel Biological Therapeutics

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Daiichi Sankyo Co Ltd, Key Facts

Daiichi Sankyo Co Ltd, Key Employees

Daiichi Sankyo Co Ltd, Key Employee Biographies

Daiichi Sankyo Co Ltd, Major Products and Services

Daiichi Sankyo Co Ltd, History

Daiichi Sankyo Co Ltd, Subsidiaries

Daiichi Sankyo Co Ltd, Joint Venture

Daiichi Sankyo Co Ltd, Key Competitors

Daiichi Sankyo Co Ltd, Ratios based on current share price

Daiichi Sankyo Co Ltd, Annual Ratios

Daiichi Sankyo Co Ltd, Annual Ratios (Cont…1)

Daiichi Sankyo Co Ltd, Annual Ratios (Cont…2)

Daiichi Sankyo Co Ltd, Interim Ratios

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Daiichi Sankyo Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Daiichi Sankyo Co Ltd, Performance Chart (2020 – 2024)

Daiichi Sankyo Co Ltd, Ratio Charts

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Daiichi Sankyo Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports